4-[(Benzenesulfonyl)methyl]-6-(phenylsulfanyl)-2-(pyridin-4-yl)pyrimidine

Catalog No. :
ACPSRP806
CAS No. :
860609-62-7
Molecular Formula :
C22H17N3O2S2
Molecular Weight :
419.53

IUPAC Name:4-((phenylsulfonyl)methyl)-6-(phenylthio)-2-(pyridin-4-yl)pyrimidine

4-[(Benzenesulfonyl)methyl]-6-(phenylsulfanyl)-2-(pyridin-4-yl)pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$325.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[(Benzenesulfonyl)methyl]-6-(phenylsulfanyl)-2-(pyridin-4-yl)pyrimidine
IUPAC Name4-((phenylsulfonyl)methyl)-6-(phenylthio)-2-(pyridin-4-yl)pyrimidine
MDL No.MFCD04124067
Molecular FormulaC22H17N3O2S2
Molecular Weight419.53
SMILESO=S(CC1=NC(C2=CC=NC=C2)=NC(SC3=CC=CC=C3)=C1)(C4=CC=CC=C4)=O
InChI KeyIGYXBIWQRLGLER-UHFFFAOYSA-N
Synonym4-[(benzenesulfonyl)methyl]-6-(phenylsulfanyl)-2-(pyridin-4-yl)pyrimidine;Pyrimidine, 4-[(phenylsulfonyl)methyl]-6-(phenylthio)-2-(4-pyridinyl)-
CAS No.860609-62-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPSRP806 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBDXE076 route compound structure diagram
    ACBDXE0763111-52-2
  4. Then
  5. ACPSRP806 route product structure diagram
    ACPSRP806860609-62-7
Inquiry

2. ACPSRP806 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBDXE076 route compound structure diagram
    ACBDXE0763111-52-2
  4. Then
  5. ACPSRP806 route product structure diagram
    ACPSRP806860609-62-7
Inquiry

Comments (0)